MedTrace Logo

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

NCT02113865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2015-03-09

No results posted yet for this study

Summary

The aim of this study is to establish a clinical score panel based on clinical, molecular and genetic parameters that allow us to stratify and obtain an early detection of patients with an increased risk of developing hepatocellular carcinoma (HCC).

Conditions

  • Acquired Immunodeficiency Syndrome Virus
  • Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
  • Hepatocellular Carcinoma

Sponsors & Collaborators

  • Fundación Mutua Madrileña

    collaborator OTHER

  • Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

    lead OTHER

Principal Investigators

  • Beatriz S Sastre, PhD · Fundación para la Investigación Biomédica del Hospital Ramón y Cajal

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-10-31
Completion
2015-02-28

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02113865 on ClinicalTrials.gov